News

Is This Stock a Buy After Acquiring a Potential Zepbound Competitor?
Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...
The Manila Times4d
Veru to Participate in the Virtual BTIG Obesity Health Forum
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...
Worldwide Healthcare Trust PLC - Annual Financial Report
Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...
The American Journal of Managed Care5d
A Call for Comprehensive, Equitable Adolescent Obesity Care
Adolescents face significant barriers to obesity medication access, despite a surge in prescriptions. Discover the ...
Managed Healthcare Executive6d
83% of Americans Unwilling to Pay More Than $100 for GLP-1s, Survey Shows
While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...